← Back to Search

Forced Aerobic Exercise for Multiple Sclerosis

N/A
Waitlist Available
Led By Susan M Linder, DPT
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1 (exercise session 1), week 12 (exercise session 24)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing two types of aerobic exercise for people with multiple sclerosis (MS) who have trouble walking. One type uses a motor to help them pedal faster, while the other lets them pedal at their own pace. The goal is to see if these exercises can help repair nerve cells and improve their ability to walk and move around.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1 (exercise session 1), week 12 (exercise session 24)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 (exercise session 1), week 12 (exercise session 24) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Biomechanical Gait Assessment
Exercise variables
Instrumented Timed Up and Go (TUG)
+3 more
Secondary study objectives
Modified Fatigue Impact Scale
To investigate the role of Klotho in promoting neuroprotection.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Forced Aerobic Exercise (FE)Experimental Treatment1 Intervention
The FE group (N=10) will complete 45 minutes of FE on the custom-engineered cycle designed to augment pedaling rate to greater than 70 revolutions per minute (RPM's). The VE group (N=10) will exercise on an identical semi-recumbent cycle ergometer at their self-selected cadence without assistance.
Group II: Voluntary Aerobic Exercise (VE)Active Control1 Intervention
The VE group (N=10) will exercise on an identical semi-recumbent cycle ergometer for 45 minutes at their self-selected cadence without assistance.

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,052 Previous Clinical Trials
1,371,094 Total Patients Enrolled
19 Trials studying Multiple Sclerosis
4,136 Patients Enrolled for Multiple Sclerosis
Susan M Linder, DPTPrincipal InvestigatorThe Cleveland Clinic

Media Library

Forced Aerobic Exercise Clinical Trial Eligibility Overview. Trial Name: NCT04906057 — N/A
Multiple Sclerosis Research Study Groups: Forced Aerobic Exercise (FE), Voluntary Aerobic Exercise (VE)
Multiple Sclerosis Clinical Trial 2023: Forced Aerobic Exercise Highlights & Side Effects. Trial Name: NCT04906057 — N/A
Forced Aerobic Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04906057 — N/A
~5 spots leftby Nov 2025